A
Anup Agarwal
Researcher at Indian Council of Medical Research
Publications - 20
Citations - 1285
Anup Agarwal is an academic researcher from Indian Council of Medical Research. The author has contributed to research in topics: Randomized controlled trial & Public health. The author has an hindex of 9, co-authored 17 publications receiving 855 citations. Previous affiliations of Anup Agarwal include Westchester Medical Center & New York Medical College.
Papers
More filters
Journal ArticleDOI
Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial).
Anup Agarwal,Aparna Mukherjee,Gunjan Kumar,Pranab Chatterjee,Tarun Bhatnagar,Pankaj Malhotra +5 more
TL;DR: This trial has high generalisability and approximates convalescent plasma use in real life settings with limited laboratory capacity and was not associated with a reduction in progression to severe covid-19 or all cause mortality.
Journal ArticleDOI
Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach
Sandip Mandal,Tarun Bhatnagar,Nimalan Arinaminpathy,Anup Agarwal,Amartya Chowdhury,Manoj V Murhekar,Raman R. Gangakhedkar,Swarup Sarkar +7 more
TL;DR: Port-of-entry-based entry screening of travellers with suggestive clinical features and from COVID-19-affected countries, would achieve modest delays in the introduction of the virus into the community, however, such measures would be insufficient to delay the outbreak by weeks or longer.
Journal ArticleDOI
The 2019 novel coronavirus disease (COVID-19) pandemic: A review of the current evidence
Pranab Chatterjee,Nazia Nagi,Anup Agarwal,Bhabatosh Das,Sayantan Banerjee,Swarup Sarkar,Nivedita Gupta,Raman R. Gangakhedkar +7 more
TL;DR: The review concludes with the key learning points from the ongoing efforts to prevent and contain COVID-19 and identifies the need to invest in health systems, community-led response mechanisms and the need for preparedness and global health security.
Posted ContentDOI
Convalescent plasma in the management of moderate COVID-19 in India: An open-label parallel-arm phase II multicentre randomized controlled trial (PLACID Trial)
Anup Agarwal,Aparna Mukherjee,Gunjan Kumar,Pranab Chatterjee,Tarun Bhatnagar,Pankaj Malhotra,B Latha,Sunita Bundas,Vivek Kumar,Ravi Dosi,Janak Kumar Khambholja,Rosemarie de Souza,Raja Rao Mesipogu,Saurabh Srivastava,Simmi Dube,Kiran Chaudhary,Subash S,Vinoth Rajendran,A Sundararajaperumal,P Balamanikandan,R S Uma Maheswari,R Jayanthi,S Ragunanthanan,Sudhir Bhandari,Ajeet Singh,Ashok Pal,Anjali Handa,Govind Rankawat,Ketan Kargirwar,Joyce Regi,Darshana Rathod,Edwin Pathrose,Nirankar Bhutaka,Mayur H Patel,Rahul J Verma,Kamal Malukani,Shivani A. Patel,Apurv Thakur,Satish Joshi,Rashmi Kulkarni,Nilay N Suthar,Nehal M Shah,Hemang M Purohit,Cherry K Shah,Monila Patel,Saket Shah,Smit H Shah,Tehsim Memon,Vishal R Beriwala,Kusum Jashnani,Fatema Ezzy,Simran Agrawal,Rakesh Bhadade,Atish M N,Tushar Madke,Vikash Kavishwar,Ramesh Waghmare,Nitin Valvi,B Thrilok Chander,A Vinaya Sekhar,Akhilesh Kumar Maurya,K Hemanth,K Nagamani,K Sudha,T Ravi Chandra,K Tushara Rao,J Vyshnavi,Rashmi Upadhyay,Shalini Bahadur,Rambha Pathak,Shikha Seth,Rakesh Gupta,Rita Saxena,Preksha Dwivedi,Reeni Malik,Deepti Chourasia,Jaya Lalwani,UM Sharma,JL Marko,Amit Suri,Vijay Kumar,Rajnish Kaushik,Parul Kodan,Bhabani Prasad Acharya,Kuldeep Kumar Gaur,Anubhav Gupta,Prerna Sachdeva,Shruti Dogra,Aikaj Jindal,M Joseph John,Avtar Singh Dhanju,Ranjana Khetrepal,Neeraj Sharma,Neetu Kukar,Divya Kavita,Rajesh Kumar,Rajesh Mahajan,Gurpreet Singh,Jaspreet Kaur,Raminder Pal Singh,Rajni Bassi,Swapneil Parikh,Om Shrivastav,Jayanthi Shastri,Maherra Desai,Shreevatsa Udupa,Varun A Bafna,Vijay Barge,Rajendra Madane,Sheetal Yadav,Sanjeev Mishra,Archana Bajpayee,Mahendra Kumar Garg,G K Bohra,Vijaylakshmi Nag,Puneeth Babu Anne,Mohd Nadeem,Pallavi Singh,Ram Niwas,Niranjan Shiwaji Khaire,Rattiram Sharma,Mini P Singh,Naresh Sachdeva,Suchet Sachdev,Rekha Hans,Vikas Suri,L N Yaddanapudi,Pvm Lakshmi,Neha Singh,Divendu Bhushan,Neeraj Kumar,Muralidhar Tambe,Sonali Salvi,Nalini Kadgi,Shashikala Sangle,Leena Nakate,Samir Joshi,Rajesh Karyakarte,Suraj Goyanka,Nimisha Sharma,Nikhil Verma,Asim Das,Monika Bahl,Nitya Wadhwa,Shreepad Bhat,Shweta Deshmukh,Vrushali Wagh,Atul Kulkarni,Tanvi Yardi,Ram S Kalgud,Purushottam Reddy,Kavitha Yevoor,Prashanth Gajula,Vivek Maleyur,Medini S,Mohith Hn,Anil Gurtoo,Ritika Sud,Sangeeta Pahuja,Anupam Prakash,Parijat Gogoi,Shailja Shukla,D Himanshu Reddy,Tulika Chandra,Saurabh Pandey,Pradeep Maurya,Ali Wahid,Kamlesh Upadhyay,Nidhi Bhatnagar,Nilima Shah,Mamta Shah,Tarak Patel,Ram Mohan Jaiswal,Ashish Jain,Shweta Sharma,Puneet Rijhwani,Naveen Gupta,Tinkal C Patel,Mahesh G Solu,Jitendra Patel,Yash Shah,Mayur Jarag,Varsha Godbole,Meenakshi Shah,Rikin Raj,Irfan Nagori,Pramod R Jha,Arti D Shah,Gowtham Yeeli,Archit Jain,Rooppreet Kaur Gill,KV Sreedhar Babu,B Suresh Babu,Alladi Mohan,B Vengamma,K Chandra Sekhar,Srinivasulu Damam,K Narsimhulu,C Aparna,G Baleswari,Ravindranath Reddy K,P Chandrasekhar,Sunil Jodharam Panjwani,Pankaj J Akholkar,Kairavi Parthesh Joshi,Pragnesh H Shah,Manish Barvaliya,Milind Baldi,Ashok Yadav,Manoj Kumar Gupta,Nitin Rawat,Dilip Chawda,M Natarajan,M Sintha,David Pradeep Kumar,Fathhur Rabbani,Vrushali Khirid Khadke,Dattatray Patki,Sonali Marathe,Clyde D Souza,Vipul Tadha,Satyam Arora,Devendra K Gupta,Seema Dua,Nitu Chauhan,Ajeet Singh Chahar,Joy John Mammen,Snehil Kumar,Dolly Daniel,Ravindraa Singh,Venkatesh Dhat,Yogesh Agarwal,Sohini Arora,Ashish Pathak,Manju Purohit,Ashish Sharma,Jayashree Sharma,Manisha Madkaikar,Kavita Joshi,Reetika Malik Yadav,Swarupa Bhagwat,Niteen D Karnik,Yojana A Gokhale,Leena Naik,Sangita Margam,Santasabuj Das,Alka Turuk,V Saravana Kumar,K Kanagasabai,R Sabarinathan,Gururaj Rao Deshpande,Sharda Sharma,Rashmi Gunjikar,Anita M. Shete,Darpan Phagiwala,Chetan Patil,Snehal Shingade,Kajal Jarande,Himanshu Kaushal,Pragya D Yadav,Gajanan N. Sapkal,Priya Abraham +261 more
TL;DR: This trial has high generalizability and approximates real-life setting of CP therapy in settings with limited laboratory capacity and a priori measurement of neutralizing antibody titres in donors and participants may further clarify the role of CP in management of COVID-19.
Journal ArticleDOI
Guidance for building a dedicated health facility to contain the spread of the 2019 novel coronavirus outbreak
Anup Agarwal,Nazia Nagi,Pranab Chatterjee,Swarup Sarkar,Devendra T. Mourya,Rima R Sahay,Rajesh Bhatia +6 more
TL;DR: In this article, the authors describe elements of design of such unit (e.g., space, infection control, waste disposal, safety of healthcare workers, partners to be involved in design and plan) which can be adapted to the context of either a new construction or makeshift construction on top of an existing structure.